Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xue-Feng Bai

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Oncoimmunology|November 20, 2012
The role of tumor expression of CD200 in tumor formation, metastasis and susceptibility to T lymphocyte adoptive transfer therapyFatemeh Talebian, Xue-Feng Bai
International Journal of Clinical and Experimental Pathology|September 12, 2008
IL27: its roles in the induction and inhibition of inflammationJoseph W Carl, Xue-Feng Bai
Current Molecular Medicine|February 22, 2008
Overcoming immune evasion in T cell therapy of cancer: lessons from animal modelsJin-Qing Liu, Xue-Feng Bai
Cancers|February 10, 2024
Therapeutic Immunomodulation in Gastric CancerVenu Akkanapally, Xue-Feng Bai, Sujit Basu
Journal of Theoretical Biology|April 2, 2013
The role of CD200-CD200R in tumor immune evasionKang-Ling Liao, Xue-Feng Bai, Avner Friedman
Plos One|October 31, 2014
Mathematical modeling of Interleukin-35 promoting tumor growth and angiogenesisKang-Ling Liao, Xue-Feng Bai, Avner Friedman
Plos One|March 18, 2014
Mathematical modeling of interleukin-27 induction of anti-tumor T cells responseKang-Ling Liao, Xue-Feng Bai, Avner Friedman
Journal of Theoretical Biology|December 17, 2023
IL-27 in combination with anti-PD-1 can be anti-cancer or pro-cancerKang-Ling Liao, Xue-Feng Bai, Avner Friedman
Frontiers in Immunology|April 17, 2023
Editorial: IL-27 in health and diseaseTomozumi Imamichi, Xue-Feng Bai, Cory Robinson, et al.
Frontiers in Immunology|March 27, 2023
Dendritic cell expression of CD24 contributes to optimal priming of T lymphocytes in lymph nodesXuejun Zhang, Chuan Yu, Jin-Qing Liu, et al.
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Oncoimmunology|November 20, 2012
The role of tumor expression of CD200 in tumor formation, metastasis and susceptibility to T lymphocyte adoptive transfer therapyFatemeh Talebian, Xue-Feng Bai
International Journal of Clinical and Experimental Pathology|September 12, 2008
IL27: its roles in the induction and inhibition of inflammationJoseph W Carl, Xue-Feng Bai
Current Molecular Medicine|February 22, 2008
Overcoming immune evasion in T cell therapy of cancer: lessons from animal modelsJin-Qing Liu, Xue-Feng Bai
Cancers|February 10, 2024
Therapeutic Immunomodulation in Gastric CancerVenu Akkanapally, Xue-Feng Bai, Sujit Basu
Journal of Theoretical Biology|April 2, 2013
The role of CD200-CD200R in tumor immune evasionKang-Ling Liao, Xue-Feng Bai, Avner Friedman
Plos One|October 31, 2014
Mathematical modeling of Interleukin-35 promoting tumor growth and angiogenesisKang-Ling Liao, Xue-Feng Bai, Avner Friedman
Plos One|March 18, 2014
Mathematical modeling of interleukin-27 induction of anti-tumor T cells responseKang-Ling Liao, Xue-Feng Bai, Avner Friedman
Journal of Theoretical Biology|December 17, 2023
IL-27 in combination with anti-PD-1 can be anti-cancer or pro-cancerKang-Ling Liao, Xue-Feng Bai, Avner Friedman
Frontiers in Immunology|April 17, 2023
Editorial: IL-27 in health and diseaseTomozumi Imamichi, Xue-Feng Bai, Cory Robinson, et al.
Frontiers in Immunology|March 27, 2023
Dendritic cell expression of CD24 contributes to optimal priming of T lymphocytes in lymph nodesXuejun Zhang, Chuan Yu, Jin-Qing Liu, et al.
Pageof 10